News – Page 137 – Endpoints News

GSK readies Blenrep's commercial re-launch in the US, and a push in second line

11 months ago

FDA approves endometrial cancer indications for Keytruda, Imfinzi

11 months ago

Life sciences investor Decheng Capital targets $700M for fifth fund

11 months ago

Janssen ordered to pay $150M over false claims around HIV drugs

11 months ago

Amgen nabs new Blincyto approval for certain type of leukemia

11 months ago

J&J cements footprint in Italy with €580M in investments over the next 5 years

11 months ago

Argenx drops post-Covid syndrome program; Mirum picks a dose for bile duct disease drug

11 months ago

Updated: FDA places partial hold on BioNTech-MediLink ADC after multiple deaths

11 months ago

J&J’s Sjögren’s disease drug shows promise in Phase 2, boosts prospects of FcRn assets in the autoimmune disease

11 months ago

Marinus reports mixed Phase 3 results on IV seizure drug

11 months ago

Aerovate’s stock craters after PAH drug fails Phase 2 study

11 months ago

It’s time to nominate your favorite private biotech for this year’s Endpoints 11

11 months ago

Deerfield backs $81M round for biotech developing antifungal therapy with less toxicity

11 months ago

Updated: Takeda’s Ovid-licensed drug fails two Phase 3 epilepsy studies

11 months ago

Nurix’s protein degrader overcomes resistance to BTK mutations in small leukemia study

11 months ago

With new data, AstraZeneca makes the case for its BTK inhibitor in a first-line setting

11 months ago

Gilead cancer drug magrolimab showed worrying trends around death

11 months ago

BIO CEO’s patriotic pivot; Step forward for Lilly’s Alzheimer’s drug; Pfizer’s gene therapy setback; ...

11 months ago

FDA asks Covid-19 vaccine makers to instead target KP.2 strain for fall season

11 months ago

Ending 'product hopping' and other patent changes could save US $3B over a decade, CBO says

11 months ago

Rare pediatric disease vouchers face uncertain future after September

11 months ago

Vaxart wins $453M in BARDA funding for oral Covid-19 vaccine

11 months ago

Autoimmune CAR-T data dump: Kyverna, Cabaletta shares fall after unveiling early-stage results

11 months ago

Takeda signs option deal for TKI inhibitor; Enveda's $55M raise

11 months ago

First page Previous page 134 135 136137138 139 140 Next page Last page